Relx (NYSE:RELX) Reaches New 52-Week High – What’s Next?

Relx Plc (NYSE:RELX)’s stock price reached a new 52-week high on Tuesday . The company traded as high as $49.58 and last traded at $49.47, with a volume of 682654 shares traded. The stock had previously closed at $49.12.

Analysts Set New Price Targets

A number of brokerages recently issued reports on RELX. Redburn Atlantic assumed coverage on shares of Relx in a research report on Wednesday, January 8th. They set a “buy” rating for the company. StockNews.com assumed coverage on Relx in a research report on Wednesday, October 30th. They issued a “hold” rating on the stock.

Relx Stock Performance

The company has a quick ratio of 0.42, a current ratio of 0.48 and a debt-to-equity ratio of 1.63. The business has a 50 day moving average price of $46.81 and a 200 day moving average price of $46.72.

Institutional Investors Weigh In On Relx

A number of institutional investors have recently made changes to their positions in the company. CENTRAL TRUST Co raised its position in Relx by 1,290.2% in the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock worth $26,000 after buying an additional 529 shares during the last quarter. Versant Capital Management Inc purchased a new position in shares of Relx during the fourth quarter valued at approximately $31,000. Private Trust Co. NA lifted its position in Relx by 119.9% during the third quarter. Private Trust Co. NA now owns 1,038 shares of the technology company’s stock valued at $49,000 after purchasing an additional 566 shares during the period. Wilmington Savings Fund Society FSB purchased a new stake in Relx in the third quarter worth approximately $125,000. Finally, Grove Bank & Trust grew its position in Relx by 10.2% in the 3rd quarter. Grove Bank & Trust now owns 3,758 shares of the technology company’s stock worth $178,000 after purchasing an additional 348 shares during the period. Hedge funds and other institutional investors own 15.02% of the company’s stock.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.